Keyword Analysis & Research: hexagon bio

Keyword Analysis

Keyword CPC PCC Volume Score Length of keyword
hexagon bio0.40.174065911
hexagon1.790.12716967
bio1.480.68881973

Keyword Research: People who searched hexagon bio also searched

Keyword CPC PCC Volume Score
hexagon bio0.680.9577345
hexagon bio menlo park ca0.960.6987941
hexagon biotech1.10.7912151
hexagon bio pharma pvt ltd0.210.4710723
hexagon biotech limited0.510.9685763
hexagon biology1.350.7289040
hexagon bio logo1.971703420
hexagon bio wiki0.120.7860026
hexagon bio stock0.190.1449088
hexagon bio address1.150.9530486
hexagon bio careers0.570.1722718
hexagon bio funding1.670.8140657
hexagon bio menlo park1.460.2225022
hexagon bio inc0.980.4202884
use of hexagon in biology and life sciences1.850.8690496
hexagon bio pipeline1.50.831871
hexagon bio crunchbase1.880.9743382

Search Results related to hexagon bio on Search Engine

  • Home - Hexagon

    hexagonbio.com

    https://www.hexagonbio.com/

    WebA world-class. interdisciplinary team. We are drug hunters, data scientists, biologists, chemists, and engineers united by a conviction that leveraging evolved medicines will improve outcomes for patients. Learn More. We turn nature’s DNA into new medicines.

    DA: 48 PA: 61 MOZ Rank: 19

  • Company - Hexagon

    hexagonbio.com

    https://www.hexagonbio.com/company/

    WebWe have assembled leading technology- and life science-focused investors who believe in and support our ambition to become the world-leading company in developing human therapeutics from metagenomes.

    DA: 97 PA: 35 MOZ Rank: 59

  • Hexagon Bio Raises $77.3 Million Series B Financing and …

    hexagonbio.com

    https://www.hexagonbio.com/hexagon-bio-raises-77-3-million-series-b-financing-and-strengthens-leadership-to-expand-novel-computational-discovery-platform-and-advance-microbial-genome-derived-small-molecules/

    WebMENLO PARK, CA, February 13, 2023 – Hexagon Bio, a biopharmaceutical company pioneering the discovery of medicines encoded in the global metagenome, today announced that it has raised a $77.3 million Series B financing and made key appointments to its leadership team.

    DA: 9 PA: 26 MOZ Rank: 37

  • Hexagon Bio Closes $47 Million in Series A Financing to …

    hexagonbio.com

    https://www.hexagonbio.com/series-a/

    WebSep 15, 2020 · Download PDF. The company is building a first-of-its-kind proprietary genomics database to reveal new secondary metabolites to combat human disease. Menlo Park, CA – Hexagon Bio, Inc. (“Hexagon”), a biotechnology company turning nature’s genomes into medicines, today announced that it has closed $47 million in Series A …

    DA: 2 PA: 84 MOZ Rank: 10

  • Hexagon Bio Raises $61 Million to Advance Novel Small-Molecule

    hexagonbio.com

    https://www.hexagonbio.com/hexagon-bio-raises-61-million-to-advance-novel-small-molecule-medicines-mined-from-microbial-genomes/

    WebMENLO PARK, CA, September 22, 2021 – Hexagon Bio, a biopharmaceutical company pioneering the discovery of medicines encoded in the global metagenome, today announced that it has raised $61 million to fuel the continued development of its platform to design and develop new therapeutics mined from microbial genomes.

    DA: 63 PA: 17 MOZ Rank: 30

  • News - Hexagon

    hexagonbio.com

    https://www.hexagonbio.com/news/

    WebFeb 13, 2023 · Hexagon Bio Raises $77.3 Million Series B Financing and Strengthens Leadership to Expand Novel Computational Discovery Platform and Advance Microbial Genome-Derived Small Molecules. Read More. Wed, Sep 22, 2021.

    DA: 73 PA: 84 MOZ Rank: 6

  • Science - Hexagon

    hexagonbio.com

    https://www.hexagonbio.com/science/

    WebAdvances in DNA sequencing have changed the landscape dramatically, revealing genes encoding those known medicines, as well as genes encoding many yet-unstudied molecules. Hexagon’s platform leverages these advances to unlock valuable molecules, particularly those directed at cancer.

    DA: 72 PA: 99 MOZ Rank: 95

  • Hexagon Bio | LinkedIn

    linkedin.com

    https://www.linkedin.com/company/hexagon-bio

    WebHexagon Bio is a data-driven biopharma company developing targeted small molecule therapeutics. Our proprietary platform combines data science, genomics, synthetic biology, chemistry and...

    DA: 42 PA: 48 MOZ Rank: 92

  • Hexagon Bio Raises $61 Million to Advance Novel Small ... - BioSpace

    biospace.com

    https://www.biospace.com/article/releases/hexagon-bio-raises-61-million-to-advance-novel-small-molecule-medicines-mined-from-microbial-genomes/

    WebSep 22, 2021 · MENLO PARK, Calif.-- ( BUSINESS WIRE )-- Hexagon Bio, a biopharmaceutical company pioneering the discovery of medicines encoded in the global metagenome, today announced that it has raised $61 million to fuel the continued development of its platform to design and develop new therapeutics mined from microbial …

    DA: 25 PA: 48 MOZ Rank: 77

  • Hexagon Bio scores $77M to target 'undruggable' cancers, …

    bizjournals.com

    https://www.bizjournals.com/sanfrancisco/news/2023/02/13/cancer-undruggable-infectious-disease-hexagon-bio.html

    WebFeb 13, 2023 · Leaders of Hexagon Bio Inc., a team of researchers hailing from Stanford University and UCLA, say their company's combination of genomics, machine learning, chemistry and synthetic biology will...

    DA: 48 PA: 64 MOZ Rank: 78